Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00043563 · ClinicalTrials.gov registry record · NA

Cognitive Behavioral Treatment of Pediatric Trichotillomania

A NA study of Trichotillomania, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT00043563: Completed NA study of Trichotillomania, sponsored by University of Pennsylvania.

NCT00043563 is a NA study of Trichotillomania that has completed, run by University of Pennsylvania. The registered enrollment target is 24 participants, below the 69-participant average among 8 other Trichotillomania trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00043563, a NA study of Trichotillomania, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This study will compare the effectiveness of cognitive-behavior therapy (CBT) to a minimal attention control (AC) condition for treatment of pediatric trichotillomania (TTM).

Primary Outcome

Semi-structured interview about hair-pulling and related symptoms

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive-Behavior Therapy

Study Locations (1)

Pennsylvania

  • Center for the Treatment and Study of Anxiety - Philadelphia

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2001-01
Est. Completion 2004-10
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT00043563 record still lists

NCT00043563 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 69-participant average among 8 other Trichotillomania trials with a reported enrollment target (65% lower).

The record links to 1 condition, with Trichotillomania appearing as the primary indexed condition, and to 1 intervention - of which Cognitive-Behavior Therapy is the first listed.

NCT00043563 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00043563 about?

NCT00043563 is a clinical study titled "Cognitive Behavioral Treatment of Pediatric Trichotillomania". This study will compare the effectiveness of cognitive-behavior therapy (CBT) to a minimal attention control (AC) condition for treatment of pediatric trichotillomania (TTM).

What is the current status of trial NCT00043563?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2001-01. Estimated completion is 2004-10.

What conditions does trial NCT00043563 study?

This clinical trial studies the following conditions: Trichotillomania.

What interventions are being tested in trial NCT00043563?

The interventions under investigation include: Cognitive-Behavior Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00043563?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00043563 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trichotillomania

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00043563's enrollment target sits among peer trials

24 6th of 8 higher than 3 of 8 other Trichotillomania trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Trichotillomania trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00043563, the US trial registry maintained by the National Library of Medicine. NCT00043563 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.